J. B. Chemicals & Pharmaceuticals Limited (BSE:506943) is looking for acquisitions. JB Chemicals & Pharmaceuticals (JB Pharma) is evaluating assets for acquisitions to bolster market share in the domestic branded formulation business, said its Chief Executive Officer Nikhil Chopra. In an interview with ET, he said the assets should be at the right valuation, and have synergy with the existing business with a payback period of about seven to eight years and a potential to grow.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,864 INR | +0.48% | +4.81% | +14.75% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.75% | 3.47B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- JBCHEPHARM Stock
- News J. B. Chemicals & Pharmaceuticals Limited
- JB Pharma Seeks Acquisitions